Bright Minds Biosciences Stock Analysis

Bright Stock Analysis Notes

About 36.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.29. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bright Minds Biosciences recorded a loss per share of 1.3. The entity had not issued any dividends in recent years. The firm had 1:5 split on the 14th of July 2023. Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT medicines to improve the lives of patients with severe and life-altering diseases. The company was incorporated in 2019 and is headquartered in Vancouver, Canada. Bright Minds is traded on NASDAQ Exchange in the United States. To learn more about Bright Minds Biosciences call Ian McDonald at 647 407 2515 or check out https://brightmindsbio.com.

Bright Minds Biosciences Investment Alerts

Bright Minds Biosciences Upcoming and Recent Events

Bright Minds Thematic Classifications

Bright Stock Institutional Investors

Note, although Bright Minds' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Bright Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.91 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bright Minds's market, we take the total number of its shares issued and multiply it by Bright Minds's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Bright Profitablity

Management Efficiency

Bright Minds Biosciences has return on total asset (ROA) of (0.3842) % which means that it has lost $0.3842 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7169) %, meaning that it created substantial loss on money invested by shareholders. Bright Minds' management efficiency ratios could be used to measure how well Bright Minds manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -1.29. The current Return On Capital Employed is estimated to decrease to -1.35. At this time, Bright Minds' Intangible Assets are most likely to increase significantly in the upcoming years.

Technical Drivers

As of the 21st of May, Bright Minds shows the Mean Deviation of 3.52, risk adjusted performance of (0.09), and Standard Deviation of 4.68. Bright Minds Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We are able to break down and analyze data for thirteen technical drivers for Bright Minds Biosciences, which can be compared to its peers. Please confirm Bright Minds Biosciences coefficient of variation and maximum drawdown to decide if Bright Minds Biosciences is priced correctly, providing market reflects its regular price of 1.15 per share. Given that Bright Minds is a hitting penny stock territory we recommend to closely look at its jensen alpha.

Bright Minds Biosciences Price Movement Analysis

Bright Minds Predictive Daily Indicators

Bright Minds Forecast Models

Bright Minds' time-series forecasting models are one of many Bright Minds' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bright Minds' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bright Minds prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bright shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bright Minds. By using and applying Bright Stock analysis, traders can create a robust methodology for identifying Bright entry and exit points for their positions.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

When running Bright Minds' price analysis, check to measure Bright Minds' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bright Minds is operating at the current time. Most of Bright Minds' value examination focuses on studying past and present price action to predict the probability of Bright Minds' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bright Minds' price. Additionally, you may evaluate how the addition of Bright Minds to your portfolios can decrease your overall portfolio volatility.

Is Bright Minds' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.